|
|
||||||||
The Journal of Immunology, Vol 147, Issue 2 528-534, Copyright © 1991 by American Association of Immunologists
ARTICLES |
WF Chen and A Zlotnik
Department of Immunology, DNAX Research Institute, Palo Alto, CA 94304.
A previous report concluded that a new cytokine, designated IL-10, is a growth cofactor for thymocytes, spleen, and lymph node cells. In this report, we have focused on the effects of IL-10 on CD8+ spleen T cells. We first observed that IL-10 enhances the growth of CD8+ T cells to IL- 2. We then investigated the effect of murine rIL-10 on the induction of murine effector CTL from CTL precursors (CTL-p) using both bulk and filler cell-free limiting-dilution cultures. IL-10 alone could not induce Con A-activated FACS-sorted CD8+ T cells either to proliferate or to generate effector CTL. In combination with IL-2, however, IL-10 augmented the cytolytic activity of effector CTL generated from Con A- activated spleen CD8+ T cells in bulk cultures incubated for 5 days. In limiting-dilution cultures (using solid-phase anti-CD3 mAb as stimulus), IL-10, in combination with IL-2, substantially increased the CTL-p frequency and augmented the cytolytic activity per clone expanded from one CD8+ T cell when compared with cells cultured in IL-2 alone. Kinetic studies showed that IL-10 is required at both early and late culture stages for optimal generation of effector CTL. The potentiating effects of IL-10 on CTL function were neutralized by an anti-IL-10 mAb. These results indicate that IL-10 has direct effects on mature T cells, and suggest that IL-10 also functions as a cytotoxic T cell differentiation factor, which promotes a higher number of IL-2- activated CTL-p to proliferate and differentiate into effector CTL. In contrast, IL-10 did not enhance significantly the lymphokine-activated killer cell activity of IL-2-grown CD8+ cytotoxic T cells.
This article has been cited by other articles:
![]() |
J.-B. Lee, K.-A Lee, and J. Chang Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation Int. Immunol., September 6, 2007; (2007) dxm072v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valentino, V. Rapisarda, L. Santarelli, M. Bracci, M. Scorcelletti, L. Di Lorenzo, F. Cassano, and L. Soleo Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers Human and Experimental Toxicology, July 1, 2007; 26(7): 551 - 556. [Abstract] [PDF] |
||||
![]() |
M. Elrefaei, F. L. Ventura, C. A. R. Baker, R. Clark, D. R. Bangsberg, and H. Cao HIV-Specific IL-10-Positive CD8+ T Cells Suppress Cytolysis and IL-2 Production by CD8+ T Cells J. Immunol., March 1, 2007; 178(5): 3265 - 3271. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wahl, P. Bochtler, R. Schirmbeck, and J. Reimann Type I IFN-Producing CD4 V{alpha}14i NKT Cells Facilitate Priming of IL-10-Producing CD8 T Cells by Hepatocytes J. Immunol., February 15, 2007; 178(4): 2083 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Foulds, M. J. Rotte, and R. A. Seder IL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection J. Immunol., August 15, 2006; 177(4): 2565 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Elrefaei, B. Barugahare, F. Ssali, P. Mugyenyi, and H. Cao HIV-Specific IL-10-Positive CD8+ T Cells Are Increased in Advanced Disease and Are Associated with Decreased HIV-Specific Cytolysis J. Immunol., January 15, 2006; 176(2): 1274 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Lopez, S. K. Adris, A. I. Bravo, Y. Chernajovsky, and O. L. Podhajcer IL-12 and IL-10 Expression Synergize to Induce the Immune-Mediated Eradication of Established Colon and Mammary Tumors and Lung Metastasis J. Immunol., November 1, 2005; 175(9): 5885 - 5894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kang and P. M. Allen Priming in the Presence of IL-10 Results in Direct Enhancement of CD8+ T Cell Primary Responses and Inhibition of Secondary Responses J. Immunol., May 1, 2005; 174(9): 5382 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurte, M. Lopez, A. Aguirre, A. Escobar, J. C. Aguillon, J. Charo, C. G. Larsen, R. Kiessling, and F. Salazar-Onfray A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells J. Immunol., August 1, 2004; 173(3): 1731 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Cook, H. E. Mischo, and J. A. Steitz The Herpesvirus saimiri Small Nuclear RNAs Recruit AU-Rich Element-Binding Proteins but Do Not Alter Host AU-Rich Element-Containing mRNA Levels in Virally Transformed T Cells Mol. Cell. Biol., May 15, 2004; 24(10): 4522 - 4533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MILANI, N. OSTLIE, W. WANG, and B. M. CONTI-FINE T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis Ann. N.Y. Acad. Sci., September 1, 2003; 998(1): 284 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Strauss, I. Knape, I. Melzner, and K.-M. Debatin Constitutive Caspase Activation and Impaired Death-Inducing Signaling Complex Formation in CD95-Resistant, Long-Term Activated, Antigen-Specific T Cells J. Immunol., August 1, 2003; 171(3): 1172 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miura, C. J. Thoburn, E. C. Bright, W. Chen, S. Nakao, and A. D. Hess Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD Blood, September 18, 2002; 100(7): 2650 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puliti, C. von Hunolstein, C. Verwaerde, F. Bistoni, G. Orefici, and L. Tissi Regulatory Role of Interleukin-10 in Experimental Group B Streptococcal Arthritis Infect. Immun., June 1, 2002; 70(6): 2862 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dorsey, N. Kundu, Q. Yang, C. S. Tannenbaum, H. Sun, T. A. Hamilton, and A. M. Fulton Immunotherapy with Interleukin-10 Depends on the CXC Chemokines Inducible Protein-10 and Monokine Induced by IFN-{gamma} Cancer Res., May 1, 2002; 62(9): 2606 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Theumer, A. G. Lopez, D. T. Masih, S. N. Chulze, and H. R. Rubinstein Immunobiological Effects of Fumonisin B1 in Experimental Subchronic Mycotoxicoses in Rats Clin. Vaccine Immunol., January 1, 2002; 9(1): 149 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. M. Johansson, A.-S. Hansson, K. S. Nandakumar, J. Backlund, and R. Holmdahl IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies J. Immunol., September 15, 2001; 167(6): 3505 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takayama, A. E. Morelli, N. Onai, M. Hirao, K. Matsushima, H. Tahara, and A. W. Thomson Mammalian and Viral IL-10 Enhance C-C Chemokine Receptor 5 but Down-Regulate C-C Chemokine Receptor 7 Expression by Myeloid Dendritic Cells: Impact on Chemotactic Responses and In Vivo Homing Ability J. Immunol., June 15, 2001; 166(12): 7136 - 7143. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Strestik, A. R. M. Olbrich, K. J. Hasenkrug, and U. Dittmer The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus) J. Gen. Virol., June 1, 2001; 82(6): 1349 - 1354. [Abstract] [Full Text] |
||||
![]() |
E. Quattrocchi, M. J. Dallman, A. P. Dhillon, A. Quaglia, G. Bagnato, and M. Feldmann Murine IL-10 Gene Transfer Inhibits Established Collagen-Induced Arthritis and Reduces Adenovirus-Mediated Inflammatory Responses in Mouse Liver J. Immunol., May 15, 2001; 166(10): 5970 - 5978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawamoto, Y. Nitta, F. Tashiro, A. Nakano, E. Yamato, H. Tahara, K. Tabayashi, and J.-i. Miyazaki Suppression of Th1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10 Int. Immunol., May 1, 2001; 13(5): 685 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Ostlie, P. I. Karachunski, W. Wang, C. Monfardini, M. Kronenberg, and B. M. Conti-Fine Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis J. Immunol., April 15, 2001; 166(8): 4853 - 4862. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Itano, W. Zhang, J. H. Ritter, T. J. McCarthy, N. S. Yew, T. Mohanakumar, and G. A. Patterson Endobronchial transfection of naked viral interleukin-10 gene in rat lung allotransplantation Ann. Thorac. Surg., April 1, 2001; 71(4): 1126 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Croxford, M. Feldmann, Y. Chernajovsky, and D. Baker Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System J. Immunol., March 15, 2001; 166(6): 4124 - 4130. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qin, Y. Ding, H. Tahara, and J. S. Bromberg Viral IL-10-Induced Immunosuppression Requires Th2 Cytokines and Impairs APC Function Within the Allograft J. Immunol., February 15, 2001; 166(4): 2385 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Abe, T. Peng, J. Sailors, R. Bucala, and C. N. Metz Regulation of the CTL Response by Macrophage Migration Inhibitory Factor J. Immunol., January 15, 2001; 166(2): 747 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Samsom, A. Annema, M. F. Geertsma, J. A. M. Langermans, P. H. P. Groeneveld, E. de Heer, and R. van Furth Interleukin-10 Has Different Effects on Proliferation of Listeria monocytogenes in Livers and Spleens of Mice Infect. Immun., August 1, 2000; 68(8): 4666 - 4672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Santin, P. L. Hermonat, A. Ravaggi, S. Bellone, S. Pecorelli, J. J. Roman, G. P. Parham, and M. J. Cannon Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes J. Virol., May 15, 2000; 74(10): 4729 - 4737. [Abstract] [Full Text] |
||||
![]() |
M. C. López and M. A. Stanley Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein J. Gen. Virol., May 1, 2000; 81(5): 1175 - 1182. [Abstract] [Full Text] |
||||
![]() |
Y. Furukawa, G. Becker, J. L. Stinn, K. Shimizu, P. Libby, and R. N. Mitchell Interleukin-10 (IL-10) Augments Allograft Arterial Disease : Paradoxical Effects of IL-10 in Vivo Am. J. Pathol., December 1, 1999; 155(6): 1929 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sharma, M. Stolina, Y. Lin, B. Gardner, P. W. Miller, M. Kronenberg, and S. M. Dubinett T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function J. Immunol., November 1, 1999; 163(9): 5020 - 5028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Zeller, A. Panoskaltsis-Mortari, W. J. Murphy, F. W. Ruscetti, S. Narula, M. G. Roncarolo, and B. R. Blazar Induction of CD4+ T Cell Alloantigen-Specific Hyporesponsiveness by IL-10 and TGF-{beta} J. Immunol., October 1, 1999; 163(7): 3684 - 3691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rouleau, F. Cottrez, M. Bigler, S. Antonenko, J. M. Carballido, A. Zlotnik, M.-G. Roncarolo, and H. Groux IL-10 Transgenic Mice Present a Defect in T Cell Development Reminiscent to SCID Patients J. Immunol., August 1, 1999; 163(3): 1420 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Kurtis, D. E. Lanar, M. Opollo, and P. E. Duffy Interleukin-10 Responses to Liver-Stage Antigen 1 Predict Human Resistance to Plasmodium falciparum Infect. Immun., July 1, 1999; 67(7): 3424 - 3429. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Azar, H. Tamim, H. N. Beyhum, M. Z. Habbal, and W. Y. Almawi Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease Clin. Vaccine Immunol., May 1, 1999; 6(3): 306 - 310. [Full Text] [PDF] |
||||
![]() |
W. Y. Almawi, H. Tamim, and S. T. Azar T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1497 - 1502. [Abstract] [Full Text] |
||||
![]() |
M. Adib-Conquy, A.-F. Petit, C. Marie, C. Fitting, and J.-M. Cavaillon Paradoxical priming effects of IL-10 on cytokine production Int. Immunol., May 1, 1999; 11(5): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Groux, F. Cottrez, M. Rouleau, S. Mauze, S. Antonenko, S. Hurst, T. McNeil, M. Bigler, M.-G. Roncarolo, and R. L. Coffman A Transgenic Model to Analyze the Immunoregulatory Role of IL-10 Secreted by Antigen-Presenting Cells J. Immunol., February 1, 1999; 162(3): 1723 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Balasa, J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes J. Immunol., October 15, 1998; 161(8): 4420 - 4427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Boulland, V. Meignin, K. Leroy-Viard, C. Copie-Bergman, J. Briere, R. Touitou, P. Kanavaros, and P. Gaulard Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas : Association with Anaplastic Large Cell Lymphomas and Nasal Natural Killer-Cell Lymphomas Am. J. Pathol., October 1, 1998; 153(4): 1229 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Petersson, J. Charo, F. Salazar-Onfray, G. Noffz, M. Mohaupt, Z. Qin, G. Klein, T. Blankenstein, and R. Kiessling Constitutive IL-10 Production Accounts for the High NK Sensitivity, Low MHC Class I Expression, and Poor Transporter Associated with Antigen Processing (TAP)-1/2 Function in the Prototype NK Target YAC-1 J. Immunol., September 1, 1998; 161(5): 2099 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S. P. Li, S. A. Moser, K. L. Bost, and J. E. Domer Cytokine Involvement in Immunomodulatory Activity Affected by Candida albicans Mannan Infect. Immun., April 1, 1998; 66(4): 1384 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Groux, M. Bigler, J. E. de Vries, and M.-G. Roncarolo Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells J. Immunol., April 1, 1998; 160(7): 3188 - 3193. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Stohlman, C. C. Bergmann, M. T. Lin, D. J. Cua, and D. R. Hinton CTL Effector Function Within the Central Nervous System Requires CD4+ T Cells J. Immunol., March 15, 1998; 160(6): 2896 - 2904. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |